3D Bioprinting of Breast Cancer Models for Drug Resistance Study
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Adipose-derived mesenchymal stem/stromal cells (ADMSC) are one of the major stromal cells in the breast cancer microenvironment that promote cancer progression. Previous studies on the effects of ADMSC on breast cancer metastasis and drug resistance, using two-dimensional (2D) cultures, remained inconclusive. In the present study, we compared cocultured ADMSC and human epidermal receptor 2 positive breast primary breast cancer cells (21PT) in 2D and three-dimensional (3D) cultures and then examined their response to doxorubicin (DOX). We examined 3D bioprinted constructs with breast cancer cells in the middle and ADMSC in the edge region, which were made by using dual hydrogel-based bioinks. We found that the percentage of cleaved Caspase-3 positive cells was significantly lower in the bioprinted constructs with ADMSC and 21PT than that in the cancer cell alone constructs, in response to low DOX dose. We further increased the thickness of the ADMSC layers to mimic the status of obesity and then examined the effect of ADMSC thickness on DOX resistance and lysyl oxidase (LOX) secretion. In the moderate and thick-layered ADMSC constructs, significantly more cells were stained negative for cleaved Caspase-3, indicating less apoptosis. Both ADMSC and 21PT intrinsically expressed LOX, regardless of changes in thickness or DOX administration. Notably, treatment with a LOX inhibitor significantly decreased the stiffness in the ADMSC region but did not affect the stiffness in the 21PT region. In addition, LOX inhibitor treatment enhanced DOX sensitivity of 21PT in the bioprinted constructs, as seen by a decrease in LOX secretion and downregulation of adenosine triphosphate-binding cassette transporter gene expression. Taken together, we demonstrate that 3D bioprinted these breast cancer models faithfully reproduce in vivo conditions and should provide better models for examining breast cancer biology and for screening for drug discoveries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An extensive body of experimental evidence has established that 3D culture systems more closely recapitulate the architecture and the physiology of human solid tumors when compared with traditional 2D systems.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [93]
In the citing paper
“While 2D systems were the first workhorses in cancer research, a vast body of experimental evidence confirms that the relevant features of the cancer progression, and the effectiveness of anticancer pharmaceutical compounds, cannot be properly recapitulated in 2D cell culture systems [8,57,93].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [93]
In the citing paper
“In recent years, bioprinting technology based on layer-by-layer printing has been used for tumor-on-a-chip fabrication (Fig. 3)132,145–147.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [145]
Citations
Cites
1 retracted
Cox, T. R., Rumney, R. M. H., Schoof, E. M., Perryman, L., Høye, A. M., Agrawal, A., Bird, D., Latif, N. A., Forrest, H., Evans, H. R., et al. (2015) · Nature · doi:10.1038/nature14492 · Cited by 482
RetractedMicroenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity
Kang, H.-W., Lee, S. J., Ko, I. K., Kengla, C., Yoo, J. J., & Atala, A. (2016) · Nature Biotechnology · doi:10.1038/nbt.3413 · Cited by 2,622
3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs
Kolesky, D. B., Truby, R. L., Gladman, A. S., Busbee, T. A., Homan, K. A., & Lewis, J. A. (2014) · Advanced Materials · doi:10.1002/adma.201305506 · Cited by 2,102
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Research works printed but not linked: 2
- Kirschmann D., 2002, Cancer Res., 62, 4478
- Band V., 1990, Cancer Res., 50, 7351
Cited by
Items 101–157 of 157
Mammary Cancer Models: An Overview from the Past to the Future
Silva, J., Oliveira, P. A., Duarte, J. A., & Faustino‐Rocha, A. I. (2024) · In Vivo · doi:10.21873/invivo.13800 · Cited by 15
“In 2018, Wang et al. demonstrated that 3D bioprinting of stromal cells from the breast cancer microenvironment replicates in vivo conditions and provides better models for studying breast cancer biology and drug discovery (47).”
Ghosh, A. K., Ghosh, S., Pati, F., & Duraiswamy, S. (2023) · Bioprinting · doi:10.1016/j.bprint.2023.e00316 · Cited by 9
Recent advances in 3D printing for in vitro cancer models
Zhang, B., Morgan, M., Teoh, X.-Y., Mackay, R., Ermler, S., & Narayan, R. J. (2024) · Journal of Applied Physics · doi:10.1063/5.0200726 · Cited by 11
Lučić, I., Kurtović, M., Mlinarić, M., Piteša, N., Gašparović, A. Č., Sabol, M., & Milković, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310683 · Cited by 11
Zhang, W., Li, Z., Yan, Y., & Shi, W. (2024) · Gels · doi:10.3390/gels10070429 · Cited by 10
“Real-time PCR reactions were performed in a StepOnePlus™ Real-Time PCR System (Thermo Scientific, Waltham, MA, USA) using SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA) with the housekeeping gene GAPDH as the internal control.”
MethodSelf-citationShukla, P., Bera, A. K., Yeleswarapu, S., & Pati, F. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202400035 · Cited by 12
The design of the spheroids-based in vitro tumor model determines its biomimetic properties
Lugovoi, M. E., Karshieva, S. S., Usatova, V. S., Voznyuk, A. A., Захарова, В. А., Levin, A. A., Petrov, S. V., Senatov, F. S., Mironov, V. A., Belousov, V. V., et al. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214178 · Cited by 7
Koskinen, L. M., Nieminen, L., Arjonen, A., Guzmán, C., Peurla, M., & Peuhu, E. (2024) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-024-09557-1 · Cited by 7
Rahman, M. M., Wells, G., Rantala, J., Helleday, T., Muthana, M., & Danson, S. J. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2336583 · Cited by 7
“Layer wise deposition of cellular and biochemical materials allows more spatial control and biomimetic tissue architecture with higher reproducibility [66].”
A 3D, Compartmental Tumor-Stromal Microenvironment Model of Patient-Derived Bone Metastasis
Garakani, M. M., Cooke, M. E., Wertheimer, M. R., Weber, M. H., Ajji, A., & Rosenzweig, D. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010160 · Cited by 6
“For example, (i) a breast cancer model was fabricated by 3D bioprinting, in which a “tumor” in the center was surrounded by a stromal compartment [33]; (ii) co-extrusion produced a core–sell structure with immune cells in the core and tumor cells in the outer layer [34]; (iii) multi-channel microfluidic devices combin…”
Method3D bioprinting of alginate for cancer therapy: A review
Rastin, H., & Abousalman‐Rezvani, Z. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145494 · Cited by 8
Chang, T.-W., Huang, M., Dong, G., & Lee, I. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c15529 · Cited by 9
Modern Methods of Preclinical Anticancer Drug Screening Using Test Systems Based on Cell Cultures
Kitaeva, K. V., Rizvanov, A. A., & Solovyeva, V. V. (2021) · Učënye zapiski Kazanskogo universiteta. Seriâ Estestvennye nauki/Učënye zapiski Kazanskogo universiteta. Seriâ Estestvennye nauki/Učenye zapiski Kazanskogo gosudarstvennogo universiteta. Seriâ Estestvennye nauki · doi:10.26907/2542-064x.2021.2.155-176 · Cited by 8
Sbirkov, Y., Redzheb, M., Forraz, N., McGUCKIN, C. P., & Sarafian, V. S. (2024) · Biomedicines · doi:10.3390/biomedicines12030665 · Cited by 6
“There are many examples from colorectal [64–66], lung [67], breast [68,69], and other types of cancer [70,71].”
BackgroundTransformative potential of three-dimensional bioprinting technology for advanced organoid research
Yoon, J., Yoon, G., & Jang, J. (2024) · Organoid · doi:10.51335/organoid.2024.4.e8 · Cited by 8
“Similarly, previous cancer research demonstrated the use of bioprinted breast cancer organoids to study tumor growth and drug resistance, marking a significant advancement in the understanding of cancer biology [44,45].”
BackgroundRecent advancements and challenges in 3D bioprinting for cancer applications
Behera, S. A., Nanda, B., & Achary, P. G. R. (2024) · Bioprinting · doi:10.1016/j.bprint.2024.e00357 · Cited by 5
Hamel, K. M., Frazier, T. P., Williams, C. C., Duplessis, T., Rowan, B. G., Gimble, J. M., & Sanchez, C. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052728 · Cited by 5
Lin, M., Jiang, D., Zhang, X., & Kang, Y. Y. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505819 · Cited by 4
“Recent studies increasingly use 3D bioprinting to develop highly accurate breast cancer models that closely mimic biological conditions, offering a reliable platform for mechanistic studies and streamlined drug screening [138].”
Bioprinting Organs—Science or Fiction?—A Review From Students to Students
Murenu, N., Mussoni, C., Mier, M. S. A., Büttner, P., Chicaiza-Cabezas, N. A., Dai, Y. R., Faber, J., Fiedler, M., Lamberger, Z., Ng, X. J., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502103 · Cited by 5
Modeling intratumor heterogeneity in breast cancer
McDonough, E., Barroso, M., Ginty, F., & Corr, D. T. (2024) · Biofabrication · doi:10.1088/1758-5090/ad9b50 · Cited by 7
“Similarly, Wang et al found that extrusion-printed 3D breast cancer models more faithfully recapitulated important in vivo conditions when evaluating response to doxorubicin using adipose-derived mesenchymal stem/stromal cells and HER2-positive primary breast cancer cells [179].”
Amens, J. N., Yang, J., Hawthorne, L., & Zorlutuna, P. (2025) · Biomaterials Science · doi:10.1039/d4bm01569j · Cited by 5
3D bioprinting of cancer models: A game-changer in drug discovery and development
Kurzątkowska, M., Frankowski, J., Sobczak, M., & Piotrowska, U. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125915 · Cited by 7
Additive Manufacturing of Smart Bionanomaterials for Fabrication of Medical Implants
Sumathy, B., Nair, L. V., Vijayan, V. M., Kumar, P. R. A., Velayudhan, S., & Thomas, V. (2022) · Wiley eBooks · doi:10.1002/9783527835478.ch16 · Cited by 3
3D bioprinting innovations: a new frontier in breast cancer research
Seifi, Z., Khazaei, M., Dayani, M., Zamani, S., Abdalla, S. B., & Rezakhani, L. (2025) · Medical Oncology · doi:10.1007/s12032-025-03069-6 · Cited by 5
“This suggests that the ADMSC layer acts not just as a physical barrier limiting DOX penetration but also actively modifies how BC cells respond to DOX [110].”
3D bioprinting for reproducing the tumor microenvironment in cancer research models
Aoun, J., Oliveira, H., Fennell, S., Diab-Assaf, M., Caldefie‐Chezet, F., & Delort, L. (2026) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2026.100385 · Cited by 6
4D Printing: The Next Dimension of Healthcare in Cancer Research
Chinnakorn, A., Nuansing, W., Kouzani, A. Z., Bodaghi, M., & Zolfagharian, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2404-2_7 · Cited by 2
Yadav, P., Mondal, P., Jani, S., Saini, D. K., & Chatterjee, K. (2025) · Virtual and Physical Prototyping · doi:10.1080/17452759.2025.2459802 · Cited by 1
“These include various cancer models such as brain cancer [61, 62], pancreatic cancer [63], lung cancer [64, 65], ovarian cancer [66], liver cancer [67, 68], breast cancer [69, 70], and metastatic models [71, 72].”
Jaiswal, C., Bhar, B., Sugihara, S., & Mandal, B. B. (2026) · Small · doi:10.1002/smll.202513199 · Cited by 2
3D bioprinting for cancer modeling and drug screening
Cadiou, A., Matera, E., Ellinger, N., Jordheim, L. P., Duruisseaux, M., Marquette, C. A., & Dumontet, C. (2026) · Biomarker Research · doi:10.1186/s40364-026-00951-x · Cited by 2
“Currently available studies (Table 6) suggest that 3D bioprinted fresh tumor samples yield interesting results in terms of interactions with cells from the TME, as well as for drug sensitivity screening.”
Biofabrication and biomedical manufacturing research frontiers in the United States
Chen, Y., Phillips, K. R., Alsberg, E., Angelini, T. E., Annabi, N., Atala, A., Bandyopadhyay, A. K., Bellan, L. M., Bertassoni, L. E., Blazeski, A., et al. (2026) · Bio-Design and Manufacturing · doi:10.1631/bdm.2600246 · Cited by 3
Self-citationPatient-Specific Tumor Microenvironment Models
Lee, J. W., Kim, J., Shin, Y., Chi, B. H., Kim, J. H., & Choi, S. Y. (2021) · Journal of Urologic Oncology · doi:10.22465/kjuo.2021.19.4.197 · Cited by 1
“또다른 유방암 연구에서 암 세포주 코어와 일차 지 방세포 유래 MSC (adipose-derived MSC, ADMSC) 로 만들어진 다양한 층수의 기질 껍질을 얻기 위해 이 중 hydrogel 기반 바이오 잉크가 압출되었다.(73) 양촉 부 분 모두 서로 다른 바이오 재료 성질을 가진 채 성공적으 로 프린트 되었다.”
In vitro Approaches to Model Breast Tumor Complexity
Rosado-Galindo, H. M., Suarez, L., & Domenech, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96338 · Cited by 3
Bioprinting functional tissues: cell types and a focus on cancer modeling
Pinos, R., Sbrana, F. V., & Scielzo, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85430-6.00005-4 · Cited by 1
3D bioprinting of a breast tumor model
Тимофеева, С. В., Filippova, S. Y., Ситковская, А., Ващенко, Л., Ausheva, T. V., Михайловна, Б. С., Михайловна, Б. С., Маслов, А., Сергеевна, Ш. Ю., Novikova, I. A., et al. (2023) · Voprosy Onkologii · doi:10.37469/0507-3758-2023-69-1-67-73 · Cited by 1
Krasnoslobodtsev, A. V. (2023) · Wiley eBooks · doi:10.1002/9783527834044.ch30 · Cited by 1
Self-citationBiofabricated three-dimensional tissue models
Berry, D. B., Yu, C., & Chen, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00077-0
Newly emerged engineering of in vitro 3D tumor models using biomaterials for chemotherapy
Cai, B., Lv, Q., Wang, Z., & Wang, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00022-8
Preclinical Cancer Models for the Evaluation of Immunotherapies: From Cell Lines to Animal Models
Pezeshki, P. S., & Rezaei, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_206-1 · Cited by 1
Cho, W.-W., Park, W., Cho, D., & Yi, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823536-2.00003-1
Importance of microfluidics in cancer modeling
Suryavanshi, P., Dharwad, P., & Bodas, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95533-1.00010-2
Amens, J. N., Yang, J., Hawthorne, L., & Zorlutuna, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.02.626455
Research Progress on 3D Bone Tumor Printing Technology
任, 乾. (2025) · Modeling and Simulation · doi:10.12677/mos.2025.141009
3D bioprinted cancer model for anticancer drug testing
Jain, P., Siddiqui, A., Parveen, S., Farooq, U., Mohapatra, S., Kumar, V., Mirza, M. A., & Iqbal, Z. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26518-1.00012-4
3D bioprinting technology in cancer management: Applications, challenges, and future perspectives
Nandy, B. C., Dutta, S., Banerjee, B., & Mondal, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26518-1.00010-0
Tumor-on-a-Chip: From Biomimetic Tumor-Immune Microenvironments to Therapeutic Insights
Çetin, Y. (2025) · Biochemistry · doi:10.5772/intechopen.1012047
Preclinical Cancer Models for the Evaluation of Immunotherapies: From Cell Lines to Animal Models
Pezeshki, P. S., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00767-4_206
Li, Y. B., Balestri, W., Desbiens, L., Maple, M. B., Boppana, T. K., Reinwald, Y., & Jezierski, A. (2025) · Biomedical engineering · doi:10.5772/intechopen.1012748 · Cited by 1
Goodarzi, S. (2021) · theses.fr (ABES) · doi:10.70675/b0a0d503z93b4z464bz93d6z36d6613fb371 · Cited by 1
Biofabrication de modèles de cancer du sein HER2-positifs par bioimpression 3D
Simoes, M. (2024) · theses.fr (ABES) · doi:10.70675/3b76e0eczc30fz440cza3bbzfc1750a015d6
Introduction and Need for 3D Printing in Biomedical Applications
Sharma, A., Shavita, Jangra, J., Patial, S. K., & Singh, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-6774-4_1
Precision Oncology for Breast Cancer: From Molecular Insights to Personalised Therapies
Banerjee, A., Tatiparthi, R., Kumar, P., & Kumar, R. (2026) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-032-24071-2_1
Advancements in Cancer Research: Exploring the Role of 3D Bioprinting
Sönmez, G., Yazarkan, Y., Aksoy, E. A., & Güllü, İ. (2026) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.70121
Clegg, J., Davern, J. W., Holloway, P. L., McFetridge, M. L., Ravichandran, A., Jeffery, P. L., Hilmi, F. S., Murekatete, B., Dargaville, T. R., Werner, C., et al. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100986 · Cited by 1
3D Bioprinting for Breast Cancer Modelling, Diagnosis, Therapeutic Testing, and Clinical Translation
Turkson, V. A., Díaz-Cruces, E., García, C. D. L. M., Troconis, J., Casanova-Carvajal, Ó., Díaz-López, S. M., Uriarte, J. J., Rodríguez-Díaz, J. M., Sousa, F. B. D., & Zamora‐Ledezma, C. (2026) · Journal of Composites Science · doi:10.3390/jcs10100519
Nakipoğlu, M., Mahmoodi, M., Apu, E. H., Shahabipour, F., Diltemiz, S. E., Saha, S., Alem, H., & Ashammakhi, N. A. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71734
Metadata
- Authors
- Wang, Y., Shi, W., Kuss, M., Mirza, S., Qi, D., Krasnoslobodtsev, A., Zeng, J., Band, H., Band, V., & Duan, B.
- Affiliations
- Shandong University (CN)
- University of Nebraska Medical Center (US)
- First Hospital of China Medical University (CN)
- University of Nebraska at Omaha (US)
- Fred and Pamela Buffett Cancer Center (US)
- Corresponding author
- Band, Vimla
- Duan, Bin
- ORCID
- Venue
- ACS Biomaterials Science & Engineering
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-15
- Volume
- 4
- Issue
- 12
- Pages
- 4401-4411
- ISSN
- 2373-9878 (ISSN-L)
- OpenAlex
- W2901604183
- Cited by
- 157
- References
- 89
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 20 · 2021: 32 · 2020: 13 · 2019: 7
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Biomaterials Science & Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Nebraska Department of Health and Human Services
- University of Nebraska Medical Center
- U.S. Department of Defense (W81XWH-17-1-0616, W81XWH-14-1-0567)
- State of Nebraska
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- 3D bioprinting, breast cancer, drug resistance, doxorubicin resistance, tumor microenvironment, lysyl oxidase, obesity, apoptosis, caspase-3, ABC transporters, tumor stiffness, HER2-positive breast cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.